Financing ·
SciSparc receives $405K from warrant holder exercising 405,728 warrants at reduced $1.00 price
SPRCSciSparc Ltd.
On October 26, 2026, SciSparc Ltd. entered into an inducement offer letter with L.I.A Pure Capital Ltd., agreeing to a reduced exercise price of $1.00 per share for existing warrants. The holder exercised warrants for up to 405,728 ordinary shares, generating approximately $405,728 in aggregate gross proceeds. The transaction is expected to close on or about October 27, 2026, subject to customary conditions. SciSparc intends to use the net proceeds for working capital and general corporate purposes. SciSparc Ltd. operates in the biotechnology sector, focusing on the development of cancer therapies.